# Open Label Optimization Study

> **NCT05819021** · — · ACTIVE_NOT_RECRUITING · sponsor: **Magnus Medical** · enrollment: 1000 (estimated)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DEVICE:** SAINT® Neuromodulation System (NMS)

## Key facts

- **NCT ID:** NCT05819021
- **Lead sponsor:** Magnus Medical
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-04-06
- **Primary completion:** 2026-10-15
- **Final completion:** 2027-04-15
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05819021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05819021, "Open Label Optimization Study". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT05819021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*